About Institut Mérieux
Institut Mérieux is a company based in Lyon (France) founded in 1897. It operates as a Professional Services. Institut Mérieux has raised $870.44 million across 1 funding round from investors including Exor. Institut Mérieux has completed 1 acquisition, including Biofire Diagnostics. Institut Mérieux offers products and services including Industrial Biology Solutions.
- Headquarter Lyon, France
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Institut Mérieux
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$870.44 M (USD)
in 1 rounds
-
Latest Funding Round
$870.44 M (USD), Private Equity Round
Jul 01, 2022
- Investors
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Institut Mérieux
Institut Mérieux offers a comprehensive portfolio of products and services, including Industrial Biology Solutions.
Solutions in biology are provided for public health improvement.
People of Institut Mérieux
Unlock access to complete
Funding Insights of Institut Mérieux
Institut Mérieux has successfully raised a total of $870.44M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $870.44 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Private Equity Round — $870.4M
-
First Round
First Round
(01 Jul 2022)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2022 | Amount | Private Equity Round - Institut Mérieux | Valuation | Exor |
|
Investors in Institut Mérieux
Institut Mérieux has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Exor.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on health insurance companies and operates multiple industries
|
Founded Year | Domain | Location |
Investments & Acquisitions by Institut Mérieux
Institut Mérieux has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Biofire Diagnostics.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Molecular diagnostic solutions for genetic condition detection are provided.
|
1990 |
Financial Statements - Institut Mérieux
Institut Mérieux Comparisons
Competitors of Institut Mérieux
Latest news on Institut Mérieux
Frequently Asked Questions about Institut Mérieux
Institut Mérieux was founded in 1897 and raised its 1st funding round 125 years after it was founded.
Institut Mérieux is headquartered in Lyon, France. It is registered at Lyon, Auvergne-rhone-alpes, France.
Institut Mérieux is a funded company, having raised a total of $870.44M across 1 funding round to date. The company's 1st funding round was a Private Equity Round of $870.44M, raised on Jul 01, 2022.
Institut Mérieux is engaged in improving medicine and public health globally through expertise in industrial biology. Activities are centered on pushing the boundaries of biology to enhance patient care and consumer health. A global, interdisciplinary approach is adopted, involving network-based solutions without borders. Sectors served include healthcare with a focus on combating infectious diseases. Strategic guidance is provided to various subsidiary companies like bioMérieux and Transgene, fostering synergies across all areas.
Institut Mérieux offers Industrial Biology Solutions.
Institut Mérieux has made 1 acquisition, including Biofire Diagnostics.
Institut Mérieux has 1 investor. Key investors include Exor.